News and Announcements
Doug Rathbone Joins Board of Leaf Resources
- Published October 21, 2016 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
21st October 2016, ASX Announcement
Leaf Resources Ltd (ASX: LER, “Leaf” or “the Company”) is pleased to announce the appointment of Mr.Doug Rathbone as a non exchange director of the Company commencing November 1, 2016.
Mr. Rathbone is currently Chairman of Rathbone Wine Group, a Director of Cotton Seed Distributors and AgBiTech, and a member of the Rabobank Advisory Board. He is a former Board member of CSIRO.
Mr. Rathbone, a chemical engineer by training, served as the Chief Executive Officer and Managing Director at Nufarm Limited from 1999 to 2015, and previously as the Managing Director of Nufarm Australia Limited from 1982.
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
